Amanda Radford serves as the Director of Medical Affairs at Asahi Kasei Pharma America, where she leverages her extensive clinical research expertise to drive innovative solutions in critical care trials. With a strong focus on sepsis and coagulopathy, Amanda has been instrumental in advancing the...
Amanda Radford serves as the Director of Medical Affairs at Asahi Kasei Pharma America, where she leverages her extensive clinical research expertise to drive innovative solutions in critical care trials. With a strong focus on sepsis and coagulopathy, Amanda has been instrumental in advancing the company’s clinical initiatives, ensuring that protocols are not only scientifically robust but also aligned with regulatory standards. Her role involves the meticulous synthesis and analysis of clinical data, which enables her to identify potential issues and propose actionable solutions that enhance study protocols and training materials.
One of Amanda's key projects involved the development of a new clinical protocol and its subsequent amendment, which was informed by comprehensive data analysis from previous studies. This process required her to conduct thorough literature reviews and craft precise responses to inquiries from ethics committees (ECs) and institutional review boards (IRBs), showcasing her strong communication skills and attention to detail. Additionally, she has performed ad hoc country-specific data analyses, providing critical insights that support the strategic direction of ongoing trials.
Amanda's collaborative approach extends to working closely with investigator sites and statisticians, ensuring that all stakeholders are aligned and informed throughout the research process. Her proficiency in clinical monitoring, regulatory submissions, and CRF design, combined with her deep understanding of therapeutic areas and biotechnology, positions her as a key contributor to Asahi Kasei Pharma America’s mission to advance medical science and improve patient outcomes. With a commitment to excellence and a passion for innovation, Amanda continues to make significant strides in the field of clinical research.
